selected scholarly activity
-
chapters
- Dose Fractionation. 103-109. 2022
- The Canadian Experience with Hypofractionation. 169-180. 2016
- Decision making in the physician-patient encounter: Revisiting the shared treatment decisionmaking model. 229-241. 2013
- The Elderly and Breast Cancer Radiotherapy. 291-305. 2006
-
conferences
- Adjunctive statistical standardization of quantitated adjuvant ER and PgR in CCTG MA.27. Journal of Clinical Oncology. 2024
- Metformin, placebo, and endocrine therapy discontinuation among participants in a randomized double-blind trial of metformin vs placebo in hormone receptor-positive early-stage breast cancer (CCTG MA32). Breast Cancer Research and Treatment. 93-102. 2023
- LUMINA: A prospective trial omitting radiotherapy (RT) following breast conserving surgery (BCS) in T1N0 luminal A breast cancer (BC).. Journal of Clinical Oncology. 2022
- OPAR: A Multicenter Phase II Randomized Trial of Fractionation Schedules for Once-a-Day Accelerated Partial Breast Irradiation (APBI). International Journal of Radiation Oncology Biology Physics. S6-S6. 2021
- A randomized phase III study of radiation doses and fractionation schedules in non-low risk ductal carcinoma in situ (DCIS) of the breast (BIG 3-07/TROG 07.01). Cancer Research. 2021
- Early discontinuation to adjuvant endocrine therapy in the ECOG-ACRIN TAILORx Trial.. Journal of Clinical Oncology. 2020
- Abstract P2-18-01: Single modality adjuvant therapy with radiation (RT) alone or endocrine therapy (ET) alone in women ≥65 years with early stage, hormone receptor positive breast cancer treated with breast-conserving surgery: A population-based analysis. Cancer Research. 2020
- Abstract P5-12-06: Non-adherence to endocrine therapy is associated with a significant increased risk of local recurrence in women ≥65 years with stage T1N0 breast cancer treated with adjuvant endocrine therapy alone after breast-conserving surgery. Cancer Research. 2020
- Abstract P6-16-01: Refined local recurrence risk estimates based on a multigene expression assay combined with clinicopathological features significantly impacts radiotherapy recommendation in patients with low/intermediate risk DCIS treated with breast-conserving surgery. Cancer Research. 2020
- Cctg MA.39 tailor RT: A randomized trial of regional radiotherapy in biomarker low-risk node-positive breast cancer (NCT03488693).. Journal of Clinical Oncology. TPS602-TPS602. 2019
- The effect of metformin on sex hormones in non-diabetic breast cancer patients in CCTG MA.32: A Phase III randomized adjuvant trial of metformin versus placebo in addition to standard therapy.. Journal of Clinical Oncology. 529-529. 2019
- Clinical benefit according to biologic subtype and extent of disease: Who should not receive radiation?. Breast. S9-S9. 2019
- Abstract ES4-2: Treatment morbidity and quality of life considerations. Cancer Research. 2019
- Abstract GS4-02: Regional lymph node irradiation in early stage breast cancer: An EBCTCG meta-analysis of 13,000 women in 14 trials. Cancer Research. 2019
- Abstract GS4-03: RAPID: A randomized trial of accelerated partial breast irradiation using 3-dimensional conformal radiotherapy (3D-CRT). Cancer Research. 2019
- Abstract GS4-07: Race, ethnicity and clinical outcomes in hormone receptor-positive, HER2-negative, node-negative breast cancer: results from the TAILORx trial. Cancer Research. 2019
- Abstract GS6-03: Symptoms and health-related quality of life on endocrine therapy alone (E) versus chemoendocrine therapy (C+E): TAILORx patient-reported outcomes results. Cancer Research. 2019
- Abstract PD1-10: Randomized phase II study comparing two different schedules of palbociclib plus second line endocrine therapy in women with estrogen receptor positive, HER2 negative advanced/metastatic breast cancer: CCTG MA38 (NCT02630693). Cancer Research. 2019
- Lung SBRT Credentialing in the Canadian LUSTRE Randomized Trial. International Journal of Radiation Oncology Biology Physics. S235-S235. 2018
- CA15-3/MUC1 in CCTG MA-32 (NCT01101438): A phase III RCT of the effect of metformin vs. placebo on invasive disease free and overall survival in early stage breast cancer (BC).. Journal of Clinical Oncology. 557-557. 2018
- Effects of radiotherapy on breast cancer outcomes among stage I, low-Recurrence risk, hormone-Sensitive breast cancer: Pooled analysis of individual data from phase III trials. Cancer Research. 2018
- A Phase 3, Multicenter, Randomized Trial to Evaluate the Symptomatic and Quality of Life Improvements in Lung Cancer Patients Receiving External Beam Radiation With or Without High Dose Rate Intraluminal Brachytherapy. International Journal of Radiation Oncology Biology Physics. S116-S116. 2017
- Long-Term Outcomes of Microinvasive Breast Cancer in the Canadian Hypofractionation Trial. International Journal of Radiation Oncology Biology Physics. S56-S57. 2017
- Breast Irradiation after Conservative Surgery: Some-More-or None. Breast. S15-S15. 2017
- Ten-Year Results of the Breast Intensity Modulated Radiation Therapy (IMRT) Randomized Controlled Trial. International Journal of Radiation Oncology Biology Physics. S5-S5. 2016
- The 21-Gene Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer Treated on SWOG S8814. International Journal of Radiation Oncology Biology Physics. S146-S146. 2016
- A randomized trial (MA.17R) of extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone or preceded by tamoxifen in postmenopausal women with early-stage breast cancer.. Journal of Clinical Oncology. 2016
- Patient-reported outcomes from MA.17R: A randomized trial of extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone or preceded by tamoxifen in postmenopausal women with early-stage breast cancer.. Journal of Clinical Oncology. 2016
- Abstract S5-08: Late side-effects of breast cancer radiotherapy: Second cancer incidence and non-breast-cancer mortality among 40,000 women in 75 trials. Cancer Research. 2016
- Acute Toxicity and Quality of Life of Hypofractionated Radiation Therapy for Breast Cancer. International Journal of Radiation Oncology Biology Physics. S59-S59. 2015
- Radiation Therapy Quality of Care Indicators for Invasive Breast Cancer. International Journal of Radiation Oncology Biology Physics. E359-E360. 2015
- Early Results of a Quality Assurance Program in a Randomized Trial of Stereotactic Body Radiotherapy for Stage I Medically Inoperable Lung Cancer. Journal of Thoracic Oncology. S327-S327. 2015
- Recurrence score and clinicopathologic characteristics of TAILORx participants by race and ethnicity.. Journal of Clinical Oncology. 2015
- The role of PET-CT in treatment decision making for women with locally advanced cervical cancer.. Journal of Clinical Oncology. 5523-5523. 2015
- PG 10.02 Evolving standards in breast cancer radiotherapy: who should receive locoregional RT?. Breast. S19-S20. 2015
- Recurrence score and clinicopathologic characteristics of TAILORx participants by race and ethnicity.. Journal of Clinical Oncology. 36-36. 2014
- Evaluation of the adjuvant radiation treatment-effect heterogeneity using genomic signature for locoregional relapse and long-term outcome.. Journal of Clinical Oncology. 1031-1031. 2014
- Prognostic and predictive significance of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trial.. Journal of Clinical Oncology. 11019-11019. 2014
- Vitamin B12 (Vit B12) biochemical (BCH) deficiency (DEF) in non-diabetic breast cancer (BC) patients on NCIC CTG MA.32: A phase III randomized adjuvant BC trial comparing metformin (Met) to placebo (Pl).. Journal of Clinical Oncology. 542-542. 2014
- Abstract A124: Characterization of claudin-low breast cancers. Molecular Cancer Research. A124-A124. 2013
- Competing risks of death in NCIC CTG MA.27 adjuvant exemestane versus anastrozole.. Journal of Clinical Oncology. 2013
- Effect of metformin versus placebo on weight and metabolic factors in initial patients enrolled onto NCIC CTG MA.32, a multicenter adjuvant randomized controlled trial in early-stage breast cancer (BC). Journal of Clinical Oncology. 2013
- Analytical Variables That Affect the Prognostic Utility of Ki67 in Invasive Breast Cancer. Modern Pathology. 74A-75A. 2013
- Analytical Variables That Affect the Prognostic Utility of Ki67 in Invasive Breast Cancer. Laboratory Investigation. 74A-75A. 2013
- Interim Toxicity Results From RAPID: A Randomized Trial of Accelerated Partial Breast Irradiation (APBI) Using 3D Conformal External Beam Radiation Therapy (3D CRT). International Journal of Radiation Oncology Biology Physics. 21-22. 2013
- Abstract P1-13-01: A randomized trial of CEF versus dose dense EC followed by paclitaxel versus AC followed by paclitaxel in women with node positive or high risk node negative breast cancer, NCIC CTG MA.21: Results of the final relapse free survival analysis.. Cancer Research. 2012
- Robotic radiosurgery for the treatment of one to three brain metastases: A pragmatic application of cost-benefit analysis using willingness to pay.. Journal of Clinical Oncology. 17-17. 2012
- Cardiac Sparing With Breath-hold Technique: A Dosimetric Evaluation of Benefits in Different Patient Populations. International Journal of Radiation Oncology Biology Physics. S257-S257. 2012
- Development of a Patient Decision Aid for Older Women With Stage I Breast Cancer Considering Adjuvant Treatment Postlumpectomy. International Journal of Radiation Oncology Biology Physics. S221-S221. 2012
- Identifying Risk Factors for Locoregional Recurrence Following Postmastectomy Radiation Therapy. International Journal of Radiation Oncology Biology Physics. S251-S251. 2012
- Open-label phase III randomized controlled trial comparing taxane-based chemotherapy (Tax) with lapatinib (L) or trastuzumab (T) as first-line therapy for women with HER2+ metastatic breast cancer: Interim analysis (IA) of NCIC CTG MA.31/GSK EGF 108919.. Journal of Clinical Oncology. LBA671-LBA671. 2012
- Impact of concurrent (CON) and sequential (SEQ) radiotherapy (RT) with adjuvant aromatase inhibitors (AI) in early-stage breast cancer (EBC): NCIC CTG MA.27.. Journal of Clinical Oncology. 2012
- Patient-reported cognitive impairments among women with breast cancer randomly assigned to hormonal therapy (HT) alone versus chemotherapy followed by hormonal therapy (C plus HT): Results from the Trial Assigning Individualized Options for Treatment (TAILORx). Journal of Clinical Oncology. 2012
- Results of a cluster randomized trial to evaluate a nursing lead supportive care intervention in newly diagnosed breast and colorectal cancer patients.. Journal of Clinical Oncology. 2012
- Claudin-Low Breast Cancer; a Molecular Subtype Associated with Poor Prognosis. Modern Pathology. 34A-34A. 2012
- Claudin-Low Breast Cancer; a Molecular Subtype Associated with Poor Prognosis. Laboratory Investigation. 34A-34A. 2012
- Morphological Characteristics of HER2 Over-Expressing and Basal-Like Breast Cancers and the Association between Lymphocytic Tumor Infiltrate and Prognosis. Modern Pathology. 25A-25A. 2012
- Morphological Characteristics of HER2 Over-Expressing and Basal-Like Breast Cancers and the Association between Lymphocytic Tumor Infiltrate and Prognosis. Laboratory Investigation. 25A-25A. 2012
- How Should We Assess Tumour Size (T Stage) in Patients with Multicentric/Multifocal Breast Cancer? Results from the NCIC CTG MA.5 Randomized Trial of CEF vs. CMF in Pre-Menopausal Women with Node Positive Breast Cancer.. Cancer Research. 2011
- P2-12-27: Simply Adding Together the Diameters of Tumor Foci in Patients with Multicentric or Multifocal Disease Does Not Add Any Additional Prognostic Information: An Analysis from NCIC CTG MA.12 Randomized Placebo-Controlled Trial of Tamoxifen after Adjuvant Chemotherapy in Pre-Menopausal Women with Early Breast Cancer.. Cancer Research. 2011
- P5-14-01: Differences in Efficacy by Assessment Method: NCIC CTG Adjuvant Breast Cancer Trials MA.5, MA.12, MA.14, MA.21, MA.27 Meta-Analysis.. Cancer Research. 2011
- P5-15-03: Development of a Patient Decision Aid for Women 70 Years and Older with Stage I, Hormonally Sensitive, Breast Cancer Considering Adjuvant Treatment Post-Lumpectomy.. Cancer Research. 2011
- NCIC-CTG MA. 20: An intergroup trial of regional nodal irradiation in early breast cancer. Journal of Clinical Oncology. 2011
- A phase III randomized trial of metformin versus placebo on recurrence and survival in early-stage breast cancer (BC) (NCIC Clinical Trials Group MA.32).. Journal of Clinical Oncology. TPS103-TPS103. 2011
- Impact of a change of body mass index (BMI) on outcome following adjuvant endocrine therapy, chemotherapy, or trastuzumab for breast cancer.. Journal of Clinical Oncology. 513-513. 2011
- NCIC CTG MA.20: An intergroup trial of regional nodal irradiation in early breast cancer.. Journal of Clinical Oncology. 2011
- Phase III study of taxane chemotherapy with lapatinib or trastuzumab as first-line therapy for women with HER2/neu-positive metastatic breast cancer (BC) (NCIC Clinical Trials Group (NCICCTG)MA.31/GSK EGF 108919).. Journal of Clinical Oncology. TPS108-TPS108. 2011
- THREE-YEAR OUTCOMES OF A CANADIAN MULTI-CENTRE STUDY OF ACCELERATED PARTIAL BREAST IRRADIATION (APBI) USING CONFORMAL RADIATION THERAP. Radiotherapy and Oncology. S26-S26. 2010
- Tamoxifen versus tamoxifen plus octreotide LAR as adjuvant therapy for early-stage breast cancer in postmenopausal women: Update of NCIC CTG MA14 trial.. Journal of Clinical Oncology. 542-542. 2010
- Outcomes of Women Who Were Premenopausal at Diagnosis of Early Stage Breast Cancer in the NCIC CTG MA17 Trial.. Cancer Research. 487S-487S. 2009
- DELTA: A Randomized Trial of Decongestive Lymphatic Therapy for Women with Lymphedema following Treatment for Breast Cancer. International Journal of Radiation Oncology Biology Physics. S53-S53. 2009
- Assessing the Coordination of Palliative Cancer Care in the Community. Journal of Palliative Care. 233-233. 2009
- Integration between primary care providers and the cancer system: Gaps and opportunities. Journal of Clinical Oncology. 2009
- A POPULATION - BASED STUDY OF THE FRACTIONATION OF POST - LUMPECTOMY BREAST RADIOTHERAPY IN ONTARIO. Radiotherapy and Oncology. S117-S117. 2008
- A POPULATION-BASED STUDY OF THE FRACTIONATION OF POST-LUMPECTOMY BREAST RADIOTHERAPY IN ONTARIO. Radiotherapy and Oncology. S42-S42. 2008
- ADJUVANT EXTERNAL BEAM RADIOTHERAPY IN THE TREATMENT OF ENDOMETRIAL CANCER: RESULTS OF THE RANDOMIZED MRC ASTEC AND NCIC EN.5 TRIALS, A SYSTEMATIC REVIEW AND META-ANALYSIS. Radiotherapy and Oncology. S22-S23. 2008
- Adjuvant External Beam Radiotherapy in the Treatment of Endometrial Cancer: Results of the Randomized MRC ASTEC and NCIC CTG EN.5 Trials, A Systematic Review and Meta-analysis. International Journal of Radiation Oncology Biology Physics. S353-S354. 2008
- INTEGRATING FAMILY PHYSICIANS INTO CANCER CARE. Radiotherapy and Oncology. S26-S27. 2008
- LONG-TERM RESULTS OF A RANDOMIZED TRIAL OF ACCELERATED HYPOFRACTIONATED WHOLE BREAST IRRADIATION FOLLOWING BREAST CONSERVING SURGERY IN WOMEN WITH NODE-NEGATIVE BREAST CANCER. Radiotherapy and Oncology. S21-S21. 2008
- Long-term Results of a Randomized Trial of Accelerated Hypofractionated Whole Breast Irradiation Following Breast Conserving Surgery in Women with Node-Negative Breast Cancer. International Journal of Radiation Oncology Biology Physics. S28-S28. 2008
- TWO-YEAR RESULTS OF THE CANADIAN FEASIBILITY STUDY OF ACCELERATED PARTIAL BREAST IRRADIATION (APBI) USING 3D CONFORMAL RADIATION THERAPY (3D-CRT). Radiotherapy and Oncology. S22-S22. 2008
- NCIC-CTG MA14 Trial: Tamoxifen (tam) vs. tam plus octreotide (oct) for adjuvant treatment of stage I or II postmenopausal breast cancer. Journal of Clinical Oncology. 2008
- Triple-negative receptor status and prognosis in the NCIC CTG MA. 21 adjuvant breast cancer trial. Journal of Clinical Oncology. 550-550. 2008
- Long-term results of a randomized trial of accelerated hypofractionated whole breast irradiation following breast conserving surgery in women with node negative breast cancer. Breast Cancer Research and Treatment. S6-S6. 2007
- An Analysis of the Real Time Radiotherapy Review Process in an International Phase III Study: MA.20. International Journal of Radiation Oncology Biology Physics. S183-S183. 2007
- The Needs of Newly Diagnosed Cancer Patients: Results of a Large Prospective Survey. International Journal of Radiation Oncology Biology Physics. S563-S563. 2007
- A low-dose ipsilateral lung constraint improves planning for partial breast irradiation. Radiotherapy and Oncology. S81-S81. 2007
- Credentialing of radiation oncologists' seroma contouring for the randomized trial of accelerated partial breast irradiation (RAPID). Radiotherapy and Oncology. S23-S23. 2007
- What is adequate radiotherapy quality assurance in phase III clinical trials involving radiation therapy?. Radiotherapy and Oncology. S29-S29. 2007
- 188 INVITED Lessons and questions from the overview. European Journal of Cancer, Supplement. 49-50. 2007
- A randomized trial of computer and pamphlet-based versions of the Decision Board (DB). Journal of Clinical Oncology. 2007
- Prospective study of specialist oncology community nursing resulting in improvements in key patient supportive care outcomes. Journal of Clinical Oncology. 2007
- Screening cancer patients for clinical trial eligibility: A randomized study. Journal of Clinical Oncology. 2007
- What can physicians do to promote patient involvement in decision making (DM) in the oncology consultation?. Journal of Clinical Oncology. 2007
- A randomized trial of CEF versus dose dense EC followed by paclitaxel versus AC followed by paclitaxel in women with node positive or high risk node negative breast cancer, NCICCTG MA. 21: Results of an interim analysis. Breast Cancer Research and Treatment. 117-117. 2007
- 28 Supportive care service needs of newly diagnosed cancer patients: Results of a population based study. Radiotherapy and Oncology. S9-S9. 2006
- 53 Initial results of a canadian feasibility study of accelerated partial breast irradiation (APBI) using 3-D conformal radiation therapy (3D CRT). Radiotherapy and Oncology. S16-S16. 2006
- A comparison of patient and physician attributes that promote patient involvement in treatment decision making in the oncology consultation.. Journal of Clinical Oncology. 325S-325S. 2006
- Agreement between physicians and patients about what constitutes shared decision making.. Journal of Clinical Oncology. 316S-316S. 2006
- NCICCTG MA.17: Tolerability of letrozole among ethnic minority women.. Journal of Clinical Oncology. 305S-305S. 2006
- Managing patients on endocrine therapy: Focus on quality-of-life issues. Clinical Cancer Research. 1056S-1060S. 2006
- The benefits of letrozole in postmenopausal women with early stage breast cancer who have had five years of tamoxifen are independent of age.. Breast Cancer Research and Treatment. S23-S23. 2006
- The role of patient values in evidence-based medicine (EBM) and its application to treatment decision-making between oncologists and women with breast cancer. Annals of Oncology. 281-281. 2006
- Determinants of preferences for starting extended adjuvant letrozole (L) in postmenopausal women following five years of tamoxifen.. Journal of Clinical Oncology. 39S-39S. 2005
- What are the supportive care service needs of recently diagnosed cancer patients? Results of a population based study. Journal of Clinical Oncology. 753S-753S. 2005
- Why Cancer Patients Enter Randomized Clinical Trials: Exploring the Factors That Influence Their Decision. Journal of Clinical Oncology. 4312-4318. 2004
- Arm lymphedema in breast cancer patients: Is it always related to treatment. International Journal of Radiation Oncology Biology Physics. S402-S402. 2004
- Clinical screening for lymphedema in breast cancer patients: Validation of Canadian guidelines.. Radiotherapy and Oncology. S42-S42. 2004
- Lymphedema in breast cancer patients screened during the first year of a randomized trial: Is treatment always the cause?. Radiotherapy and Oncology. S42-S42. 2004
- An audiotape intervention to enhance informed consent to clinical trials in breast oncology. Psycho-Oncology. S32-S33. 2004
- Assessment of quality of life (QOL) in MA.17, a randomized placebo-controlled trial of letrozole in postmenopausal women following five years of tamoxifen. Journal of Clinical Oncology. 7S-7S. 2004
- Cancer patients and the Internet: A randomized controlled trial (RCT) evaluating an intervention to facilitate physician and patient information exchange from the Internet (I).. Journal of Clinical Oncology. 553S-553S. 2004
- Patterns of trastuzumab (T) use in three Canadian provinces.. Journal of Clinical Oncology. 35S-35S. 2004
- Perceptions of job stress and its consequences in medical oncology personnel. Psycho-Oncology. S175-S175. 2003
- Comparison of HER2/neu status evaluated by FISH and two methods of quantitative PCR. Modern Pathology. 42A-42A. 2003
- Comparison of HER2/neu status evaluated by FISH and two methods of quantitative PCR. Laboratory Investigation. 42A-42A. 2003
- HER2 status: A Canadian experience of concordance between central and local testing laboratories. Breast Cancer Research and Treatment. S70-S70. 2003
- Ten-year outcome of breast-conserving surgery (BCS) and radiotherapy (RT) in women with breast cancer (BC) and germline BRCA 1/2 mutations: results from an international collaboration. Breast Cancer Research and Treatment. S7-S7. 2003
- Urgent genetic assessment (GA) in the management of newly diagnosed familial breast cancer (br ca) patients: a feasibility study. Breast Cancer Research and Treatment. S76-S77. 2003
- Use of health services and supportive care services by women with advanced breast cancer toward the end of life: Results of a longitudinal study. Journal of Palliative Care. 209-209. 2002
- The NCIC CTG MA.14 experience with the gallbladder toxicity of octreotide pamoate (oncolar) in a postmenopausal patient population undergoing adjuvant treatment for stage 1-3 breast cancer. European Journal of Cancer. S93-S93. 2002
- The effects of radiation therapy on quality of life of women with breast carcinoma. Cancer. 2260-2266. 2000
- Nurse-physician collaboration in an ambulatory cancer setting: Benefits for supportive care. Psycho-Oncology. 56-56. 1999
- The initial health assessment: A form that has changed nursing practice. Psycho-Oncology. 61-61. 1999
- Offering a choice between two adjuvant chemotherapy regimens: a pilot study to develop a decision aid for women with breast cancer. Patient Education and Counseling. 283-291. 1999
- 99 The effects of radiation therapy on quality of life in women with breast cancer: Results of a randomized trial. International Journal of Radiation Oncology Biology Physics. 184-184. 1997
- Is ipsilateral breast tumor recurrence an independent predictor of distant disease?. International Journal of Radiation Oncology Biology Physics. 149-150. 1993
-
journal articles
- Toxicity in patients receiving radiotherapy for ultracentral stage I non-small cell lung cancer: A secondary analysis of the LUSTRE randomized trial.. Radiotherapy and Oncology. 202:110605. 2024
- OPAR: A Randomized Trial of Partial Breast Irradiation in Five Fractions Once Daily for Early Breast Cancer.. Journal of Clinical Oncology. JCO2400600. 2024
- A Randomized Trial of Hypofractionated Post-Mastectomy Radiation Therapy (PMRT) in Women with Breast Reconstruction (RT CHARM, Alliance A221505). International Journal of Radiation Oncology Biology Physics. 120:s11. 2024
- Stereotactic vs Hypofractionated Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: The LUSTRE Phase 3 Randomized Clinical Trial.. JAMA Oncology. 10. 2024
- Adjunctive Statistical Standardization of Adjuvant Estrogen Receptor and Progesterone Receptor in Canadian Cancer Trials Group MA.27 Postmenopausal Breast Cancer Trial of Exemestane Versus Anastrozole. Journal of Clinical Oncology. 42:2887-2898. 2024
- Incidence of Intraoperative Cardiothoracic Intervention During Open Surgery Following Acute Posterior Sternoclavicular Joint Injury: A Case Series and Review of the Literature.. Journal of Pediatric Orthopaedics. 44:421-426. 2024
- Clinical and Genomic Risk for Late Breast Cancer Recurrence and Survival. NEJM Evid. 3:EVIDoa2300267. 2024
- Breast cancer learning health system: Patient information from a data and analytics platform characterizes care provided. Learning Health Systems. 8:e10409. 2024
- Adjunctive statistical standardization of quantitated adjuvant ER and PgR in CCTG MA.27.. Journal of Clinical Oncology. 42:567-567. 2024
- Ductal carcinoma in situ of the breast: finding the balance between overtreatment and undertreatment. The Lancet. 403:2734-2746. 2024
- Abstract PO1-27-10: Adjunctive statistical standardization of quantitated machine image analysis of Estrogen and Progesterone Receptors: CCTG MA.27 trial. Cancer Research. 84. 2024
- Measurement of adverse cosmesis in breast cancer: A deep learning approach. Expert Systems With Applications. 238:122209-122209. 2024
- Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline. Practical Radiation Oncology. 14:112-132. 2024
- Publisher's Note. Practical Radiation Oncology. 14:133-133. 2024
- LUMINA: Using molecular biomarkers to guide decision making for breast radiotherapy. Radiotherapy and Oncology. 190:110074-110074. 2024
- Optimal adjuvant therapy in older (≥70 years of age) women with low-risk early-stage breast cancer. npj Breast Cancer. 9:99. 2023
- Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer. Journal of Clinical Oncology. 41:5356-5362. 2023
- Ki67 assessment protocol as an integral biomarker for avoiding radiotherapy in the LUMINA breast cancer trial. Histopathology. 83:903-911. 2023
- Omitting Radiotherapy in Luminal A Breast Cancer. New England Journal of Medicine. 389:1727-1728. 2023
- Omitting Radiotherapy in Luminal A Breast Cancer.. New England Journal of Medicine. 389:1727. 2023
- Long-Term Toxicity in Patients Receiving Radiotherapy for Ultracentral Stage I Non-Small Cell Lung Cancer – A Secondary Analysis of the LUSTRE Randomized Trial. International Journal of Radiation Oncology Biology Physics. 117:S171-S171. 2023
- 128 Long-Term Toxicity in Patients Receiving Radiotherapy for Ultracentral Stage I Non-Small Cell Lung Cancer - A Secondary Analysis of the Lustre Randomized Trial. Radiotherapy and Oncology. 186:S59-S59. 2023
- Omitting Radiotherapy after Breast-Conserving Surgery in Luminal A Breast Cancer. New England Journal of Medicine. 389:612-619. 2023
- BRACHY: A Randomized Trial to Evaluate Symptom Improvement in Advanced Non-Small Cell Lung Cancer Treated With External Beam Radiation With or Without High-Dose-Rate Intraluminal Brachytherapy. International Journal of Radiation Oncology Biology Physics. 116:601-610. 2023
- Breast cancer mortality in 500 000 women with early invasive breast cancer diagnosed in England, 1993-2015: population based observational cohort study. The BMJ. 381:e074684-e074684. 2023
- 164P Adjuvant radiation therapy amongst immigrant and Canadian-born/long-term resident women with breast cancer. ESMO Open. 8:101504-101504. 2023
- A phase 2 study of stereotactic body radiation therapy for squamous cell carcinoma of the head and neck (SHINE): a single arm clinical trial protocol. BMC Cancer. 23:379. 2023
- Long-term outcomes and effects of hypofractionated radiotherapy in microinvasive breast cancer: Analysis from a randomized trial. Breast. 68:189-193. 2023
- Abstract GS1-05: Trial Assigning Individualized Options for Treatment (TAILORx): An Update Including 12-Year Event Rates. Cancer Research. 83. 2023
- Abstract P4-02-16: Prognostic and Predictive Capacity of Tumor Infiltrating Lymphocytes in the MA.20 regional radiotherapy trial. Cancer Research. 83. 2023
- Abstract P6-04-02: Ki67 Assessment Protocol: Companion Diagnostic Biomarker for LUMINA Prospective Cohort Study. Cancer Research. 83. 2023
- In Response to Morgan et al. and Li et al.. International Journal of Radiation Oncology Biology Physics. 115:1012-1013. 2023
- Recent Advances in Optimizing Radiation Therapy Decisions in Early Invasive Breast Cancer. Cancers. 15:1260-1260. 2023
- A Meta-Analysis of Trials of Partial Breast Irradiation. International Journal of Radiation Oncology Biology Physics. 115:60-72. 2023
- Optimal adjuvant therapy in older (≥70 years of age) women with low-risk early-stage breast cancer. npj Breast Cancer. 9. 2023
- LUSTRE: A Phase III Randomized Trial of Stereotactic Body Radiotherapy (SBRT) vs. Conventionally Hypofractionated Radiotherapy (CRT) for Medically Inoperable Stage I Non-Small Cell Lung Cancer (NSCLC). International Journal of Radiation Oncology Biology Physics. 114:1061-1062. 2022
- Lung SBRT credentialing in the Canadian OCOG-LUSTRE randomized trial. Clinical and Translational Radiation Oncology. 37:145-152. 2022
- Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3–07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study. The Lancet. 400:431-440. 2022
- LUMINA: A prospective trial omitting radiotherapy (RT) following breast conserving surgery (BCS) in T1N0 luminal A breast cancer (BC).. Journal of Clinical Oncology. 40:LBA501-LBA501. 2022
- Metformin, placebo, and endocrine therapy discontinuation among participants in a randomized double-blind trial of metformin versus placebo in hormone receptor–positive early-stage breast cancer (CCTG MA32).. Journal of Clinical Oncology. 40:526-526. 2022
- Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer. Journal of the American Medical Association (JAMA). 327:1963-1963. 2022
- Assessment of Racial Disparity in Survival Outcomes for Early Hormone Receptor–Positive Breast Cancer After Adjusting for Insurance Status and Neighborhood Deprivation. JAMA Oncology. 8:579-579. 2022
- Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials. The Lancet Oncology. 23:382-392. 2022
- Abstract GS1-08: CCTGMA.32, a phase III randomized double-blind placebo controlled adjuvant trial of metformin (MET) vs placebo (PLAC) in early breast cancer (BC): Results of the primary efficacy analysis (clinical trials.gov NCT01101438). Cancer Research. 82. 2022
- Fatigue and endocrine symptoms among women with early breast cancer randomized to endocrine versus chemoendocrine therapy: Results from the TAILORx patient‐reported outcomes substudy. Cancer. 128:536-546. 2022
- Cancer Antigen 15-3/Mucin 1 Levels in CCTG MA.32: A Breast Cancer Randomized Trial of Metformin vs Placebo. JNCI Cancer Spectrum. 5. 2021
- Association of Modifiable Risk Factors With Early Discontinuation of Adjuvant Endocrine Therapy. JAMA Oncology. 7:1196-1196. 2021
- Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials. The Lancet Oncology. 22:1139-1150. 2021
- DUCHESS: an evaluation of the ductal carcinoma in situ score for decisions on radiotherapy in patients with low/intermediate-risk DCIS. Breast Cancer Research and Treatment. 188:133-139. 2021
- Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial. npj Breast Cancer. 7:74. 2021
- Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial. Journal of the National Cancer Institute. 113:390-399. 2021
- Abstract GS2-04: A randomized phase III study of radiation doses and fractionation schedules in non-low risk ductal carcinoma in situ (DCIS) of the breast (BIG 3-07/TROG 07.01). Cancer Research. 81:gs2-04-gs2-04. 2021
- The Effect of Metformin vs Placebo on Sex Hormones in Canadian Cancer Trials Group MA.32. Journal of the National Cancer Institute. 113:192-198. 2021
- A pilot study of stereotactic boost for malignant epidural spinal cord compression: clinical significance and initial dosimetric evaluation. Radiation Oncology. 15:267. 2020
- Accelerated Partial Breast Irradiation (APBI): Where Are We Now?. Current Breast Cancer Reports. 12:275-284. 2020
- Hypofractionated Breast Irradiation: What’s Next?. Journal of Clinical Oncology. 38:3245-3247. 2020
- Acute Toxicity and Quality of Life of Hypofractionated Radiation Therapy for Breast Cancer. International Journal of Radiation Oncology Biology Physics. 107:943-948. 2020
- Accelerated Partial Breast Irradiation and Intraoperative Partial Breast Irradiation: Reducing the Burden of Effective Breast Conservation. Journal of Clinical Oncology. 38:2254-2262. 2020
- Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx. Journal of Clinical Oncology. 38:1875-1886. 2020
- Early discontinuation to adjuvant endocrine therapy in the ECOG-ACRIN TAILORx Trial.. Journal of Clinical Oncology. 38:7004-7004. 2020
- Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial. The Lancet Oncology. 21:685-698. 2020
- Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer. JAMA Oncology. 6:505-505. 2020
- International comparison of cosmetic outcomes of breast conserving surgery and radiation therapy for women with ductal carcinoma in situ of the breast. Radiotherapy and Oncology. 142:180-185. 2020
- External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial. The Lancet. 394:2165-2172. 2019
- Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions. JNCI Cancer Spectrum. 3:pkz049. 2019
- Toronto Workshop on Late Recurrence in Estrogen Receptor–Positive Breast Cancer: Part 1: Late Recurrence: Current Understanding, Clinical Considerations. JNCI Cancer Spectrum. 3:pkz050. 2019
- The time-varying effect of radiotherapy after breast-conserving surgery for DCIS. Breast Cancer Research and Treatment. 178:221-230. 2019
- Development and Validation of a Nomogram to Predict Lymphedema After Axillary Surgery and Radiation Therapy in Women With Breast Cancer From the NCIC CTG MA.20 Randomized Trial. International Journal of Radiation Oncology Biology Physics. 105:165-173. 2019
- Patterns of adjuvant care and outcomes of elderly women with stage I breast cancer after breast-conserving surgery: a population-based analysis. Breast Cancer Research and Treatment. 176:657-667. 2019
- Corrections to “De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017”. Annals of Oncology. 30:1181-1181. 2019
- Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer. New England Journal of Medicine. 380:2395-2405. 2019
- Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials. The Lancet. 393:1440-1452. 2019
- Effects of Radiotherapy in Early-Stage, Low-Recurrence Risk, Hormone-Sensitive Breast Cancer. Journal of the National Cancer Institute. 110:1370-1379. 2018
- Simulation Modeling of Cancer Clinical Trials: Application to Omitting Radiotherapy in Low-risk Breast Cancer. Journal of the National Cancer Institute. 110:1360-1369. 2018
- Correction to: De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. Annals of Oncology. 29:2153-2153. 2018
- Effect of Positron Emission Tomography Imaging in Women With Locally Advanced Cervical Cancer. JAMA network open. 1:e182081-e182081. 2018
- Systemic Effects of Radiotherapy in Ductal Carcinoma In Situ. JAMA network open. 1:e181102-e181102. 2018
- Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer. New England Journal of Medicine. 379:111-121. 2018
- Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03). Breast Cancer Research and Treatment. 169:537-548. 2018
- Evaluation of a specialized oncology nursing supportive care intervention in newly diagnosed breast and colorectal cancer patients following surgery: a cluster randomized trial. Supportive Care in Cancer. 26:1533-1541. 2018
- Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Practical Radiation Oncology. 8:145-152. 2018
- Quality of Life From Canadian Cancer Trials Group MA.17R: A Randomized Trial of Extending Adjuvant Letrozole to 10 Years. Journal of Clinical Oncology. 36:563-571. 2018
- Abstract P2-11-01: Effects of radiotherapy on breast cancer outcomes among stage I, low-Recurrence risk, hormone-Sensitive breast cancer: Pooled analysis of individual data from phase III trials. Cancer Research. 78:p2-11-01-p2-11-01. 2018
- Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. The Lancet Oncology. 19:27-39. 2018
- Reply to ‘The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology’ by Kirova et al.. Annals of Oncology. 29:281-282. 2018
- De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. Annals of Oncology. 28:1700-1712. 2017
- Effects of metformin versus placebo on vitamin B12 metabolism in non-diabetic breast cancer patients in CCTG MA.32. Breast Cancer Research and Treatment. 164:371-378. 2017
- Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trials. Annals of Oncology. 28:1560-1568. 2017
- Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials. Journal of Clinical Oncology. 35:1641-1649. 2017
- Radiation therapy quality indicators for invasive breast cancer. Radiotherapy and Oncology. 123:288-293. 2017
- Reply to L.B. Marks et al. Journal of Clinical Oncology. 35:1258-1259. 2017
- Canadian Phase III Randomized Trial of Stereotactic Body Radiotherapy Versus Conventionally Hypofractionated Radiotherapy for Stage I, Medically Inoperable Non–Small-Cell Lung Cancer – Rationale and Protocol Design for the Ontario Clinical Oncology Group (OCOG)-LUSTRE Trial. Clinical Lung Cancer. 18:250-254. 2017
- Abstract P4-12-09: The immune response in triple negative breast cancer. Cancer Research. 77:p4-12-09-p4-12-09. 2017
- Claudin-Low Breast Cancer; Clinical & Pathological Characteristics. PLoS ONE. 12:e0168669-e0168669. 2017
- Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update. Annals of Surgical Oncology. 24:38-51. 2017
- The benefit of deep inspiration breath hold: evaluating cardiac radiation exposure in patients after mastectomy and after breast-conserving surgery. Breast Cancer. 24:86-91. 2017
- Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update. Journal of Clinical Oncology. 34:4431-4442. 2016
- Ten years results of the Canadian breast intensity modulated radiation therapy (IMRT) randomized controlled trial. Radiotherapy and Oncology. 121:414-419. 2016
- The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signatures. BMC Cancer. 16:555. 2016
- Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years. New England Journal of Medicine. 375:209-219. 2016
- A randomized trial (MA.17R) of extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone or preceded by tamoxifen in postmenopausal women with early-stage breast cancer.. Journal of Clinical Oncology. 34:LBA1-LBA1. 2016
- Patient-reported outcomes from MA.17R: A randomized trial of extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone or preceded by tamoxifen in postmenopausal women with early-stage breast cancer.. Journal of Clinical Oncology. 34:LBA506-LBA506. 2016
- A randomized trial (MA.17R) of extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone or preceded by tamoxifen in postmenopausal women with early-stage breast cancer.. Journal of Clinical Oncology. 34:LBA1-LBA1. 2016
- Patient-reported outcomes from MA.17R: A randomized trial of extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone or preceded by tamoxifen in postmenopausal women with early-stage breast cancer.. Journal of Clinical Oncology. 34:LBA506-LBA506. 2016
- Competing risks of death in women treated with adjuvant aromatase inhibitors for early breast cancer on NCIC CTG MA.27. Breast Cancer Research and Treatment. 156:343-349. 2016
- Radiation of the Internal Mammary Nodes: Is There a Benefit?. Journal of Clinical Oncology. 34:297-299. 2016
- Locoregional Treatment in Early Stage Breast Cancer: More Evidence and Yet More Questions?. Clinical Oncology. 27:689-691. 2015
- Prospective Validation of a 21-Gene Expression Assay in Breast Cancer. New England Journal of Medicine. 373:2005-2014. 2015
- Regional Nodal Irradiation in Early-Stage Breast Cancer. New England Journal of Medicine. 373:1877-1880. 2015
- Regional Nodal Irradiation in Early-Stage Breast Cancer.. New England Journal of Medicine. 373:1879-1880. 2015
- Regional Nodal Irradiation in Early-Stage Breast Cancer.. New England Journal of Medicine. 373:1877-1878. 2015
- Regional Nodal Irradiation in Early-Stage Breast Cancer.. New England Journal of Medicine. 373:1878. 2015
- Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. The Lancet. 386:1341-1352. 2015
- Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015. Annals of Oncology. 26:1533-1546. 2015
- Regional Nodal Irradiation in Early-Stage Breast Cancer. New England Journal of Medicine. 373:307-316. 2015
- Identification of a Low-Risk Luminal A Breast Cancer Cohort That May Not Benefit From Breast Radiotherapy. Journal of Clinical Oncology. 33:2035-2040. 2015
- Recurrence score and clinicopathologic characteristics of TAILORx participants by race and ethnicity.. Journal of Clinical Oncology. 33:533-533. 2015
- Lapatinib or Trastuzumab Plus Taxane Therapy for Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: Final Results of NCIC CTG MA.31. Journal of Clinical Oncology. 33:1574-1583. 2015
- Predictors of Adverse Cosmetic Outcome in the RAPID Trial: An Exploratory Analysis. International Journal of Radiation Oncology Biology Physics. 91:968-976. 2015
- Effect of Metformin vs Placebo on and Metabolic Factors in NCIC CTG MA.32. Journal of the National Cancer Institute. 107:djv006-djv006. 2015
- The Bipartisan Colon. Journal of the National Cancer Institute. 107:djv011-djv011. 2015
- Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trial. Breast Cancer Research and Treatment. 149:439-448. 2015
- Enablers and barriers to using patient decision aids in early stage breast cancer consultations: a qualitative study of surgeons’ views. Implementation Science. 9:174. 2014
- Treatment crossovers in time-to-event non-inferiority randomised trials of radiotherapy in patients with breast cancer. BMJ Open. 4:e006531-e006531. 2014
- Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. The Lancet. 383:2127-2135. 2014
- Radiotherapy for breast cancer, the TARGIT-A trial. The Lancet. 383:1716-1717. 2014
- Tumor factors predictive of response to hypofractionated radiotherapy in a randomized trial following breast conserving therapy. Annals of Oncology. 25:992-998. 2014
- Treatment decision-making in the medical encounter: Comparing the attitudes of French surgeons and their patients in breast cancer care. Patient Education and Counseling. 94:230-237. 2014
- Empirical comparison of methods for analyzing multiple time-to-event outcomes in a non-inferiority trial: a breast cancer study. BMC Medical Research Methodology. 13:44. 2013
- Physician‐related facilitators and barriers to patient involvement in treatment decision making in early stage breast cancer: perspectives of physicians and patients. Health Expectations. 16:373-384. 2013
- Robotic Radiosurgery for the Treatment of 1–3 Brain Metastases: A Pragmatic Application of Cost-Benefit Analysis Using Willingness-To-Pay. Technology in Cancer Research and Treatment. 12:517-523. 2013
- Interim Cosmetic and Toxicity Results From RAPID: A Randomized Trial of Accelerated Partial Breast Irradiation Using Three-Dimensional Conformal External Beam Radiation Therapy. Journal of Clinical Oncology. 31:4038-4045. 2013
- Do alternative methods of measuring tumor size, including consideration of multicentric/multifocal disease, enhance prognostic information beyond TNM staging in women with early stage breast cancer: an analysis of the NCIC CTG MA.5 and MA.12 clinical trials. Breast Cancer Research and Treatment. 142:143-151. 2013
- In Reply to Berrang et al. International Journal of Radiation Oncology Biology Physics. 87:633-633. 2013
- Randomized Trial of Decongestive Lymphatic Therapy for the Treatment of Lymphedema in Women With Breast Cancer. Journal of Clinical Oncology. 31:3758-3763. 2013
- Women’s perceptions of their involvement in treatment decision making for early stage breast cancer. Supportive Care in Cancer. 21:1717-1723. 2013
- Competing risks of death in NCIC CTG MA.27 adjuvant exemestane versus anastrozole.. Journal of Clinical Oncology. 31:564-564. 2013
- Effect of metformin versus placebo on weight and metabolic factors in initial patients enrolled onto NCIC CTG MA.32, a multicenter adjuvant randomized controlled trial in early-stage breast cancer (BC).. Journal of Clinical Oncology. 31:1033-1033. 2013
- A Population-Based Study of the Fractionation of Postlumpectomy Breast Radiation Therapy. International Journal of Radiation Oncology Biology Physics. 86:51-57. 2013
- Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole. Annals of Oncology. 24:355-361. 2013
- Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole.. Annals of Oncology. 24:355-361. 2013
- Development of Patients’ Decision Aid for Older Women With Stage I Breast Cancer Considering Radiotherapy After Lumpectomy. International Journal of Radiation Oncology Biology Physics. 84:30-38. 2012
- Impact of concurrent (CON) and sequential (SEQ) radiotherapy (RT) with adjuvant aromatase inhibitors (AI) in early-stage breast cancer (EBC): NCIC CTG MA.27.. Journal of Clinical Oncology. 30:500-500. 2012
- Open-label phase III randomized controlled trial comparing taxane-based chemotherapy (Tax) with lapatinib (L) or trastuzumab (T) as first-line therapy for women with HER2+ metastatic breast cancer: Interim analysis (IA) of NCIC CTG MA.31/GSK EGF 108919.. Journal of Clinical Oncology. 30:LBA671-LBA671. 2012
- Patient-reported cognitive impairments among women with breast cancer randomly assigned to hormonal therapy (HT) alone versus chemotherapy followed by hormonal therapy (C+HT): Results from the Trial Assigning Individualized Options for Treatment (TAILORx).. Journal of Clinical Oncology. 30:9020-9020. 2012
- Results of a cluster randomized trial to evaluate a nursing lead supportive care intervention in newly diagnosed breast and colorectal cancer patients.. Journal of Clinical Oncology. 30:6035-6035. 2012
- Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials. The Lancet. 379:432-444. 2012
- P2-12-23: How Should We Assess Tumour Size (T Stage) in Patients with Multicentric/Multifocal Breast Cancer? Results from the NCIC CTG MA.5 Randomized Trial of CEF vs. CMF in Pre-Menopausal Women with Node Positive Breast Cancer.. Cancer Research. 71:p2-12-23-p2-12-23. 2011
- Three-Year Outcomes of a Canadian Multicenter Study of Accelerated Partial Breast Irradiation Using Conformal Radiation Therapy. International Journal of Radiation Oncology Biology Physics. 81:1220-1227. 2011
- Randomized Trial of Tamoxifen Versus Combined Tamoxifen and Octreotide LAR Therapy in the Adjuvant Treatment of Early-Stage Breast Cancer in Postmenopausal Women: NCIC CTG MA.14. Journal of Clinical Oncology. 29:3869-3876. 2011
- NCIC-CTG MA.20: An intergroup trial of regional nodal irradiation in early breast cancer.. Journal of Clinical Oncology. 29:LBA1003-LBA1003. 2011
- NCIC CTG MA.20: An intergroup trial of regional nodal irradiation in early breast cancer.. Journal of Clinical Oncology. 29:LBA1003-LBA1003. 2011
- The Impact of Specialized Oncology Nursing on Patient Supportive Care Outcomes. Journal of Psychosocial Oncology. 29:286-307. 2011
- Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents. Breast Cancer Research and Treatment. 126:215-220. 2011
- Altered Fractionation: Rationale and Justification for Whole and Partial Breast Hypofractionated Radiotherapy. Seminars in Radiation Oncology. 21:55-65. 2011
- The cluster-randomized Quality Initiative in Rectal Cancer trial: evaluating a quality-improvement strategy in surgery. CANADIAN MEDICAL ASSOCIATION JOURNAL. 182:1301-1306. 2010
- Hypofractionated Radiotherapy for Breast Cancer. New England Journal of Medicine. 362:1843-1844. 2010
- It's a choice to move forward: women's perceptions about treatment decision making in recurrent ovarian cancer. Psycho-Oncology. 19:318-325. 2010
- Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer. New England Journal of Medicine. 362:513-520. 2010
- Evaluating health-related quality of life and priority health problems in patients with prostate cancer: A strategy for defining the role of the advanced practice nurse. Canadian Oncology Nursing Journal. 20:5-14. 2010
- In Reply to Dr. Beal et al. International Journal of Radiation Oncology Biology Physics. 76:638-639. 2010
- Évaluation de la qualité de vie liée à la santé et des problèmes de santé prioritaires chez les patients atteints du cancer de la prostate : stratégie de définition du rôle des infirmières en pratique avancée. Canadian Oncology Nursing Journal. 20:E1-E11. 2010
- Who Is Responsible? The Role of Family Physicians in the Provision of Supportive Cancer Care. JCO Oncology Practice. 6:19-24. 2010
- Outcomes of Women Who Were Premenopausal at Diagnosis of Early Stage Breast Cancer in the NCIC CTG MA17 Trial.. Cancer Research. 69:13-13. 2009
- Accelerated Partial Breast Irradiation Consensus Statement from the American Society for Radiation Oncology (ASTRO). Journal of the American College of Surgeons. 209:269-277. 2009
- Accelerated Partial Breast Irradiation Consensus Statement From the American Society for Radiation Oncology (ASTRO). International Journal of Radiation Oncology Biology Physics. 74:987-1001. 2009
- Coordination of palliative cancer care in the community: “unfinished business”. Supportive Care in Cancer. 17:819-828. 2009
- Implementing patient decision support tools: Moving beyond academia?. Patient Education and Counseling. 76:120-125. 2009
- The statutory duty of physicians to inform patients versus unmet patients’ information needs: The case of breast cancer in France. Health Policy. 91:162-173. 2009
- Integration between primary care providers and the cancer system: Gaps and opportunities. Journal of Clinical Oncology. 27:6584-6584. 2009
- Are Cancer-Related Decision Aids Effective? A Systematic Review and Meta-Analysis. Journal of Clinical Oncology. 27:974-985. 2009
- Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. The Lancet. 373:137-146. 2009
- Assessing the Quality of Decision Support Technologies Using the International Patient Decision Aid Standards instrument (IPDASi). PLoS ONE. 4:e4705-e4705. 2009
- A mixed-method evaluation of nurse-led community-based supportive cancer care. Supportive Care in Cancer. 16:1343-1352. 2008
- Extended Adjuvant Endocrine Therapy in Breast Cancer: Current Status and Future Directions. Clinical Cancer Updates. 2:11-17. 2008
- The Quality Initiative in Rectal Cancer (QIRC) trial: study protocol of a cluster randomized controlled trial in surgery. BMC Surgery. 8:4. 2008
- Women's perceptions of their treatment decision-making about breast cancer treatment. Patient Education and Counseling. 73:431-436. 2008
- Clinical Experience Using Hypofractionated Radiation Schedules in Breast Cancer. Seminars in Radiation Oncology. 18:257-264. 2008
- Extended Adjuvant Endocrine Therapy in Breast Cancer: Current Status and Future Directions. Clinical Breast Cancer. 8:411-417. 2008
- Association of Phosphorylated Epidermal Growth Factor Receptor with Survival in Patients with Locally Advanced Non-small Cell Lung Cancer Treated with Radiotherapy. Journal of Thoracic Oncology. 3:716-722. 2008
- Lymphedema in women with breast cancer: characteristics of patients screened for a randomized trial. Breast Cancer Research and Treatment. 110:337-342. 2008
- NCIC-CTG MA14 Trial: Tamoxifen (tam) vs. tam + octreotide (oct) for adjuvant treatment of stage I or II postmenopausal breast cancer. Journal of Clinical Oncology. 26:532-532. 2008
- HER2 testing in a population-based study of patients with metastatic breast cancer treated with trastuzumab (Archives of Pathology and Laboratory Medicine (2008) 132, (61-65). Archives of Pathology and Laboratory Medicine. 132:730. 2008
- HER2 testing in a population-based study of patients with metastatic breast cancer treated with trastuzumab (vol 132, pg 61, 2008). Archives of Pathology and Laboratory Medicine. 132:730-730. 2008
- Efficacy, Toxicity, and Quality of Life in Older Women With Early-Stage Breast Cancer Treated With Letrozole or Placebo After 5 Years of Tamoxifen: NCIC CTG Intergroup Trial MA.17. Journal of Clinical Oncology. 26:1956-1964. 2008
- The feasibility and responsiveness of the health utilities index in patients with early-stage breast cancer: A prospective longitudinal study. Quality of Life Research. 17:333-345. 2008
- Providing supportive care to cancer patients: a study on inter-organizational relationships. International Journal of Integrated Care. 8:e01. 2008
- Statement of the Science Concerning Locoregional Treatments After Preoperative Chemotherapy for Breast Cancer: A National Cancer Institute Conference. Journal of Clinical Oncology. 26:791-797. 2008
- HER2 Testing in a Population-Based Study of Patients With Metastatic Breast Cancer Treated With Trastuzumab. Archives of Pathology and Laboratory Medicine. 132:61-65. 2008
- Improving Communication Between Doctors and Breast Cancer Patients. Annals of Family Medicine. 5:387-394. 2007
- A randomized trial of computer and pamphlet-based versions of the Decision Board (DB). Journal of Clinical Oncology. 25:6508-6508. 2007
- Prospective study of specialist oncology community nursing resulting in improvements in key patient supportive care outcomes. Journal of Clinical Oncology. 25:9107-9107. 2007
- Screening cancer patients for clinical trial eligibility: A randomized study. Journal of Clinical Oncology. 25:6529-6529. 2007
- What can physicians do to promote patient involvement in decision making (DM) in the oncology consultation?. Journal of Clinical Oncology. 25:19553-19553. 2007
- Standardized audiotape versus recorded consultation to enhance informed consent to a clinical trial in breast oncology. Psycho-Oncology. 16:371-376. 2007
- Randomized, Double-Blind, Placebo-Controlled Trial of Erythropoietin in Non–Small-Cell Lung Cancer With Disease-Related Anemia. Journal of Clinical Oncology. 25:1027-1032. 2007
- A systematic review of information in decision aids. Health Expectations. 10:46-61. 2007
- Adjuvant Chemotherapy for Breast Cancer — 30 Years Later. New England Journal of Medicine. 355:1920-1922. 2006
- Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancer. Annals of Oncology. 17:1637-1643. 2006
- Cultural influences on the physician–patient encounter: The case of shared treatment decision-making. Patient Education and Counseling. 63:262-267. 2006
- Consumer impact of an interactive decision aid for rectal cancer patients offered adjuvant therapy. Colorectal Disease. 8:676-682. 2006
- Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. The BMJ. 333:417-0. 2006
- In Reply. Journal of Clinical Oncology. 24:4038a-4039. 2006
- Cross-Border Referral for Early Breast Cancer: An Analysis of Radiation Fractionation Patterns. Current Oncology. 13:124-129. 2006
- Influence of hospital characteristics on operative death and survival of patients after major cancer surgery in Ontario.. Canadian Journal of Surgery. 49:251-258. 2006
- A comparison of patient and physician attributes that promote patient involvement in treatment decision making in the oncology consultation. Journal of Clinical Oncology. 24:6098-6098. 2006
- Agreement between physicians and patients about what constitutes shared decision making. Journal of Clinical Oncology. 24:6065-6065. 2006
- NCIC CTG MA.17: Tolerability of letrozole among ethnic minority women. Journal of Clinical Oncology. 24:6018-6018. 2006
- Understanding decision supports (DS) for women with breast cancer eligible for clinical trials (CT). Journal of Clinical Oncology. 24:10534-10534. 2006
- Ten-Year Multi-Institutional Results of Breast-Conserving Surgery and Radiotherapy in BRCA1/2-Associated Stage I/II Breast Cancer. Journal of Clinical Oncology. 24:2437-2443. 2006
- Randomized Trial of Long-Term Follow-Up for Early-Stage Breast Cancer: A Comparison of Family Physician Versus Specialist Care. Journal of Clinical Oncology. 24:848-855. 2006
- The Importance of Reporting Patient Recruitment Details in Phase III Trials. Journal of Clinical Oncology. 24:843-845. 2006
- Managing Patients on Endocrine Therapy: Focus on Quality-of-Life Issues. Clinical Cancer Research. 12:1056s-1060s. 2006
- Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. The Lancet. 366:2087-2106. 2005
- Assessment of Quality of Life in MA.17: A Randomized, Placebo-Controlled Trial of Letrozole After 5 Years of Tamoxifen in Postmenopausal Women. Journal of Clinical Oncology. 23:6931-6940. 2005
- In Reply:. Journal of Clinical Oncology. 23:6267-6267. 2005
- The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. International Journal of Radiation Oncology Biology Physics. 63:37-46. 2005
- The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma. International Journal of Radiation Oncology Biology Physics. 63:47-55. 2005
- Determinants of preferences for starting extended adjuvant letrozole (L) in postmenopausal women following five years of tamoxifen. Journal of Clinical Oncology. 23:642-642. 2005
- Treatment decision aids: conceptual issues and future directions. Health Expectations. 8:114-125. 2005
- What are the supportive care service needs of recently diagnosed cancer patients? Results of a population based study. Journal of Clinical Oncology. 23:8096-8096. 2005
- Clinical trial update: National Cancer Institute of Canada. Breast Cancer Research. 7:48-51. 2005
- Using administrative databases to measure waiting times for patients undergoing major cancer surgery in Ontario, 1993-2000.. Canadian Journal of Surgery. 48:137-142. 2005
- Physician/Patient Decision Aids for Adjuvant Therapy. Journal of Clinical Oncology. 23:1627-1630. 2005
- Use of Conventional Radiation Therapy As Part of Breast-Conserving Treatment. Journal of Clinical Oncology. 23:1718-1725. 2005
- American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Status Report 2004. Journal of Clinical Oncology. 23:619-629. 2005
- American Society of Clinical Oncology Technology Assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: Status report 2004. Journal of Clinical Oncology. 23:619-629. 2005
- More Evidence That Locoregional Radiation Therapy Improves Survival: What Should We Do?. Journal of the National Cancer Institute. 97:82-84. 2005
- Outcomes of postmastectomy radiotherapy. CANADIAN MEDICAL ASSOCIATION JOURNAL. 172:18-18. 2005
- Outcomes of postmastectomy radiotherapy. CANADIAN MEDICAL ASSOCIATION JOURNAL. 172:19-19. 2005
- Job stress and job satisfaction of cancer care workers. Psycho-Oncology. 14:61-69. 2005
- Radiation Therapy and Tamoxifen: Concurrent or Sequential? That Is the Question. Journal of Clinical Oncology. 23:1-4. 2005
- Radiotherapy fractionation for the palliation of uncomplicated painful bone metastases – an evidence-based practice guideline. BMC Cancer. 4:71. 2004
- Self‐reported use of shared decision‐making among breast cancer specialists and perceived barriers and facilitators to implementing this approach. Health Expectations. 7:338-348. 2004
- Breast cancer: New radiation treatment options - The Arthur/Morris/Vicini article reviewed. Oncology. 18:1637-1638. 2004
- The Arthur/Morris/Vicini article reviewed. Oncology. 18:1637-1638. 2004
- Towards improving the co-ordination of supportive cancer care services in the community. Health Policy. 70:125-131. 2004
- Arm lymphedema in breast cancer patients: Is it always related to treatment. International Journal of Radiation Oncology Biology Physics. 60:S402-S402. 2004
- Helping patients decide: Use of a decision aid for breast cancer surgery. Journal of Clinical Outcomes Management. 11:546-550. 2004
- The difference between study recommendations, stated policy, and actual practice in a clinical trial. Annals of Oncology. 15:1267-1273. 2004
- Effect of a Decision Aid on Knowledge and Treatment Decision Making for Breast Cancer Surgery. Journal of the American Medical Association (JAMA). 292:435-435. 2004
- Assessment of quality of life (QOL) in MA.17, a randomized placebo-controlled trial of letrozole in postmenopausal women following five years of tamoxifen. Journal of Clinical Oncology. 22:517-517. 2004
- Assessment of quality of life (QOL) in MA.17, a randomized placebo-controlled trial of letrozole in postmenopausal women following five years of tamoxifen. Journal of Clinical Oncology. 22:517-517. 2004
- Cancer patients and the Internet: A randomized controlled trial (RCT) evaluating an intervention to facilitate physician and patient information exchange from the Internet (I). Journal of Clinical Oncology. 22:6139-6139. 2004
- Cancer patients and the Internet: A randomized controlled trial (RCT) evaluating an intervention to facilitate physician and patient information exchange from the Internet (I). Journal of Clinical Oncology. 22:6139-6139. 2004
- Patterns of trastuzumab (T) use in three Canadian provinces. Journal of Clinical Oncology. 22:633-633. 2004
- Patterns of trastuzumab (T) use in three Canadian provinces. Journal of Clinical Oncology. 22:633-633. 2004
- Accuracy of ultrasound in localization of breast boost field. Radiotherapy and Oncology. 72:61-66. 2004
- Family caregiver burden: results of a longitudinal study of breast cancer patients and their principal caregivers. CANADIAN MEDICAL ASSOCIATION JOURNAL. 170:1795-1801. 2004
- Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy. CANADIAN MEDICAL ASSOCIATION JOURNAL. 170:1263-1273. 2004
- Clinical practice guidelines for the care and treatment of breast cancer: 15. Treatment for women with stage III or locally advanced breast cancer. CANADIAN MEDICAL ASSOCIATION JOURNAL. 170:983-994. 2004
- In regard to fortin et al., int j radiat oncol biol phys 2003;56:1013–1022. International Journal of Radiation Oncology Biology Physics. 58:1317-1318. 2004
- Workshop on Partial Breast Irradiation: State of the Art and the Science, Bethesda, MD, December 8-10, 2002. Journal of the National Cancer Institute. 96:175-184. 2004
- The Initial Health Assessment: an intervention to identify the supportive care needs of cancer patients. Supportive Care in Cancer. 12:19-24. 2004
- A Clinical Trial of Breast Radiation Therapy Versus Breast and Regional Radiation Therapy in Early-Stage Breast Cancer: The MA20 Trial. Clinical Breast Cancer. 4:361-363. 2003
- A Consensus Development Approach to Define National Research Priorities in Bone Metastases: Proceedings from NCIC CTG Workshop. Clinical Oncology. 15:496-499. 2003
- A Phase I–II study in the use of acupuncture-like transcutaneous nerve stimulation in the treatment of radiation-induced xerostomia in head-and-neck cancer patients treated with radical radiotherapy. International Journal of Radiation Oncology Biology Physics. 57:472-480. 2003
- American Society of Clinical Oncology Technology Assessment Working Group Update: Use of Aromatase Inhibitors in the Adjuvant Setting. Journal of Clinical Oncology. 21:2597-2599. 2003
- Erratum to “Women’s perceptions about treatment decision making for ovarian cancer”. Gynecologic Oncology. 90:232-232. 2003
- RESPONSE: Re: Randomized Trial of Breast Irradiation Schedules After Lumpectomy for Women With Lymph Node-Negative Breast Cancer. Journal of the National Cancer Institute. 95:759-759. 2003
- Re: Randomized Trial of Breast Irradiation Schedules After Lumpectomy for Women With Lymph Node-Negative Breast Cancer. Journal of the National Cancer Institute. 95:759-759. 2003
- Re: Is Less More? Lessons in Radiation Schedules in Breast Cancer. Journal of the National Cancer Institute. 95:685-686. 2003
- Helping Patients Make Informed Choices: A Randomized Trial of a Decision Aid for Adjuvant Chemotherapy in Lymph Node-Negative Breast Cancer. Journal of the National Cancer Institute. 95:581-587. 2003
- Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. International Journal of Radiation Oncology Biology Physics. 55:594-605. 2003
- Shared Treatment Decision Making: What Does It Mean to Physicians?. Journal of Clinical Oncology. 21:932-936. 2003
- Clinical practice guidelines for the care and treatment of breast cancer: breast radiotherapy after breast-conserving surgery (summary of the 2003 update).. CANADIAN MEDICAL ASSOCIATION JOURNAL. 168:437-439. 2003
- Treatment of the Internal Mammary Nodes in Early Breast Cancer: Back to the Future. Clinical Oncology. 15:14-16. 2003
- Women’s perceptions about treatment decision making for ovarian cancer. Gynecologic Oncology. 88:89-95. 2003
- Defining patient-based minimal clinically important effect sizes: a study in palliative radiotherapy for painful unresectable pelvic recurrences from rectal cancer. International Journal of Radiation Oncology Biology Physics. 54:661-669. 2002
- A Trial of Two Questions. Journal of Clinical Oncology. 20:4135-4138. 2002
- Factors that influence the recruitment of patients to Phase III studies in oncology. Cancer. 95:1584-1591. 2002
- Randomized Trial of Breast Irradiation Schedules After Lumpectomy for Women With Lymph Node-Negative Breast Cancer. Journal of the National Cancer Institute. 94:1143-1150. 2002
- American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors as Adjuvant Therapy for Women With Hormone Receptor–Positive Breast Cancer: Status Report 2002. Journal of Clinical Oncology. 20:3317-3327. 2002
- Impact of cancer-related decision aids.. Evidence report/technology assessment (Summary). 1-4. 2002
- Radiotherapy for Breast Cancer. New England Journal of Medicine. 346:862-864. 2002
- Radiotherapy for breast cancer.. New England Journal of Medicine. 346:862-864. 2002
- Decision-Making Process--Communicating Risk/Benefits: Is There an Ideal Technique?. Journal of the National Cancer Institute. Monographs. 2001:143-145. 2001
- Defining patient expressed minimal clinically important effect size (MCIES) for the relief of cancer pain. International Journal of Radiation Oncology Biology Physics. 51:52-52. 2001
- Meta-analysis of single-fraction versus multi-fraction radiotherapy trials for palliation of painful bone metastases. International Journal of Radiation Oncology Biology Physics. 51:53-53. 2001
- The use of acupuncture-like transcutaneous nerve stimulation (CODETRON) in the treatment of radiation-induced xerostomia in head and neck cancer patients treated with radical radiotherapy. International Journal of Radiation Oncology Biology Physics. 51:411-411. 2001
- Internet Use Among Physicians, Nurses, and Their Patients. Journal of the American Medical Association (JAMA). 286:1451-1452. 2001
- Baseline staging tests in primary breast cancer: a practice guideline.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 164:1439-1444. 2001
- Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology*. Journal of Clinical Oncology. 19:1539-1569. 2001
- The McCarthy/Swain article reviewed. Oncology. 14:1284-+. 2000
- Cancer care workers in Ontario: prevalence of burnout, job stress and job satisfaction.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 163:166-169. 2000
- The effects of radiation therapy on quality of life of women with breast carcinoma. Cancer. 88:2260-2266. 2000
- How to improve communication between doctors and patients. The BMJ. 320:1220-1221. 2000
- Does Locoregional Radiation Therapy Improve Survival in Breast Cancer? A Meta-Analysis. Journal of Clinical Oncology. 18:1220-1229. 2000
- Editorial: special conference issue. Health Expectations. 3:1-5. 2000
- Lessons learned from the Decision Board: a unique and evolving decision aid. Health Expectations. 3:69-76. 2000
- Use of capecitabine in stage IV breast cancer: An evidence summary. Current Oncology. 7:84-90. 2000
- Use of vinorelbine in stage IV breast cancer: An evidence summary. Current Oncology. 7:24-28. 2000
- Are Some Palliative Care Delivery Systems More Effective and Efficient than Others? A Systematic Review of Comparative Studies. Journal of Palliative Care. 15:40-47. 1999
- What do we mean by partnership in making decisions about treatment?. The BMJ. 319:780-782. 1999
- Decision-making in the physician–patient encounter: revisiting the shared treatment decision-making model. Social Science and Medicine. 49:651-661. 1999
- Mastectomy or Lumpectomy? Helping Women Make Informed Choices. Journal of Clinical Oncology. 17:1727-1727. 1999
- The role of adjuvant systemic therapy in node-negative breast cancer. Current Oncology. 6:78-89. 1999
- Use of biphosphonates in patients with bone metastases from breast cancer. Current Oncology. 6:144-154. 1999
- Management of ductal carcinoma in situ of the breast. Provincial Breast Cancer Disease Site Group.. Cancer Prevention and Control. 2:312-319. 1998
- Evaluation of a patient file folder to improve the dissemination of written information materials for cancer patients. Cancer. 83:1620-1625. 1998
- The physician–patient encounter: The physician as a perfect agent for the patient versus the informed treatment decision-making model. Social Science and Medicine. 47:347-354. 1998
- A randomized trial comparing combination of iridium implant and external beam radiation vs. external beam radiation alone in node negative locally advanced cancer of the prostate: Preliminary report. International Journal of Radiation Oncology Biology Physics. 42:302-302. 1998
- Breast radiotherapy after breast-conserving surgery. CANADIAN MEDICAL ASSOCIATION JOURNAL. 158:S35-S42. 1998
- Doing Nothing is No Choice: Lay Constructions of Treatment Decision‐making Among Women with Early‐stage Breast Cancer. Sociology of Health and Illness. 20:71-95. 1998
- Erratum: Surgical management of early stage invasive breast cancer (stage I and II) (Cancer Prevention and Control (1997) 1 (10-17)). Cancer Prevention and Control. 1:132. 1997
- The supportive care needs of newly diagnosed cancer patients attending a regional cancer center. Cancer. 80:1518-1524. 1997
- Breast irradiation in women with early stage invasive breast cancer following breast conservation surgery. Provincial Breast Disease Site Group.. Cancer Prevention and Control. 1:228-240. 1997
- Economic analyses. International Journal of Radiation Oncology Biology Physics. 38:907-908. 1997
- Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer. Cancer/Radiotherapie. 1:266-267. 1997
- Radiation therapy following breast conservation surgery: Can it ever be avoided?. Annals of Oncology. 8:217-218. 1997
- Shared decision-making in the medical encounter: What does it mean? (or it takes at least two to tango). Social Science and Medicine. 44:681-692. 1997
- Evidence for CEA utilization following curative resection of colorectal cancer. GI Cancer. 2:153-158. 1997
- Surgical management of early stage invasive breast cancer (stage I and II). Provincial Breast Disease Site Group.. Cancer Prevention and Control. 1:10-17. 1997
- The clinical practice guideline: an evolving health care technology.. Cancer Prevention and Control. 1:7-8. 1997
- Randomized Clinical Trial of Breast Irradiation Following Lumpectomy and Axillary Dissection for Node-Negative Breast Cancer: an Update. Journal of the National Cancer Institute. 88:1659-1664. 1996
- Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group.. Journal of the National Cancer Institute. 88:1659-1664. 1996
- Patients’ Preferences for Therapy in Advanced Epithelial Ovarian Cancer: Development, Testing, and Application of a Bedside Decision Instrument. Gynecologic Oncology. 62:329-335. 1996
- A randomised trial of two information packages distributed to new cancer patients before their initial appointment at a regional cancer centre. British Journal of Cancer. 73:1588-1593. 1996
- The role of palliative radiotherapy for brain metastases.. The Canadian journal of oncology. 6 Suppl 1:48-53. 1996
- 2005 The effect of delay in initiating radiotherapy post-lumpectomy on local breast recurrence. International Journal of Radiation Oncology Biology Physics. 36:280-280. 1996
- Patient preference for high or low dose rate brachytherapy in carcinoma of the cervix. Medical Dosimetry. 20:143-143. 1995
- In response to Drs. Yaes and Yu. International Journal of Radiation Oncology Biology Physics. 32:552-553. 1995
- Breast irradiation postlumpectomy: development and evaluation of a decision instrument.. Journal of Clinical Oncology. 13:847-853. 1995
- Patient preference for high or low dose rate brachytherapy in carcinoma of the cervix. Radiotherapy and Oncology. 33:187-194. 1994
- Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: results from a randomized trial. Investigators of the Ontario Clinical Oncology Group.. International Journal of Radiation Oncology Biology Physics. 30:11-16. 1994
- Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: Results from a randomized trial. International Journal of Radiation Oncology Biology Physics. 30:11-16. 1994
- Adjuvant radiotherapy for early breast cancer: patterns of practice in Ontario.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 149:1273-1277. 1993
- Complications of whole abdominal and pelvic radiotherapy following chemotherapy for advanced ovarian cancer. International Journal of Radiation Oncology Biology Physics. 22:853-858. 1992
-
other